News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gene Express Announces Licensing Agreement With NeoGenomics Laboratories



8/11/2008 8:58:56 AM

WILMINGTON, NC--(Marketwire - August 11, 2008) - Gene Express, Inc. today announced that it has signed three definitive agreements with NeoGenomics Laboratories to license the SEM Center and StaRT-PCR™ (Standardized Reverse Transcription Polymerase Chain Reaction) Technology. NeoGenomics will support Gene Express in its FDA validation of its Lung Cancer Risk Prediction and BCR/ABL tests. The agreements will also allow NeoGenomics to commercialize Gene Express diagnostic tests, validate future Gene Express technology to fulfill FDA requirements, and utilize StaRT-PCR for their own commercial activities. These agreements succeed in establishing a key validation and commercialization partnership between Gene Express and NeoGenomics.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES